Iliopoulou Marianthi, Skouras Vasileios, Psaroudaki Zoe, Makarona Magda, Vogiatzakis Evangelos, Tsorlini Eleni, Katsifa Eleni, Spyratos Dionisios, Siopi Dimitra, Kotsiou Ourania, Xitsas Stelios, Martsoukou Maria, Sigala Ioanna, Kalomenidis Ioannis
7th Respiratory Medicine, Athens Chest Hospital "Sotiria", Athens, Greece.
Department of Pulmonary Medicine, 401 General Army Hospital, Athens, Greece.
J Thorac Dis. 2021 Feb;13(2):521-532. doi: 10.21037/jtd-20-2786.
Community-acquired pleural infection (CAPI) is a growing health problem worldwide. Although most CAPI patients recover with antibiotics and pleural drainage, 20% require surgical intervention. The use of inappropriate antibiotics is a common cause of treatment failure. Awareness of the common causative bacteria along with their patterns of antibiotic resistance is critical in the selection of antibiotics in CAPI-patients. This study aimed to define CAPI bacteriology from the positive pleural fluid cultures, determine effective antibiotic regimens and investigate for associations between clinical features and risk for death or antibiotic-resistance, in order to advocate with more invasive techniques in the optimal timing.
We examined 158 patients with culture positive, CAPI collected both retrospectively (2012-2013) and prospectively (2014-2018). Culture-positive, CAPI patients hospitalized in six tertiary hospitals in Greece were prospectively recruited (N=113). Bacteriological data from retrospectively detected patients were also used (N=45). Logistic regression analysis was performed to identify clinical features related to mortality, presence of certain bacteria and antibiotic resistance.
Streptococci, especially the non-pneumococcal ones, were the most common bacteria among the isolates, which were mostly sensitive to commonly used antibiotic combinations. RAPID score (i.e., clinical score for the stratification of mortality risk in patients with pleural infection; parameters: renal, age, purulence, infection source, and dietary factors), diabetes and CRP were independent predictors of mortality while several patient co-morbidities (e.g., diabetes, malignancy, chronic renal failure, etc.) were related to the presence of certain bacteria or antibiotic resistance.
The dominance of streptococci among pleural fluid isolates from culture-positive, CAPI patients was demonstrated. Common antibiotic regimens were found highly effective in CAPI treatment. The predictive strength of RAPID score for CAPI mortality was confirmed while additional risk factors for mortality and antibiotic resistance were detected.
社区获得性胸膜感染(CAPI)在全球范围内是一个日益严重的健康问题。尽管大多数CAPI患者通过抗生素治疗和胸腔引流得以康复,但仍有20%的患者需要手术干预。使用不恰当的抗生素是治疗失败的常见原因。了解常见病原菌及其抗生素耐药模式对于CAPI患者抗生素的选择至关重要。本研究旨在通过阳性胸腔积液培养确定CAPI的细菌学特征,确定有效的抗生素治疗方案,并研究临床特征与死亡风险或抗生素耐药性之间的关联,以便在最佳时机提倡采用更具侵入性的技术。
我们对158例培养阳性的CAPI患者进行了研究,这些患者的数据既有回顾性收集的(2012 - 2013年),也有前瞻性收集的(2014 - 2018年)。前瞻性招募了在希腊六家三级医院住院的培养阳性的CAPI患者(N = 113)。还使用了回顾性检测患者的细菌学数据(N = 45)。进行逻辑回归分析以确定与死亡率、特定细菌的存在和抗生素耐药性相关的临床特征。
链球菌,尤其是非肺炎链球菌,是分离出的最常见细菌,它们大多对常用抗生素组合敏感。RAPID评分(即胸膜感染患者死亡风险分层的临床评分;参数:肾脏、年龄、脓性、感染源和饮食因素)、糖尿病和CRP是死亡率的独立预测因素,而一些患者合并症(如糖尿病、恶性肿瘤、慢性肾衰竭等)与特定细菌的存在或抗生素耐药性有关。
本研究证实了在培养阳性的CAPI患者的胸腔积液分离物中链球菌占主导地位。发现常用抗生素治疗方案对CAPI治疗非常有效。证实了RAPID评分对CAPI死亡率的预测强度,同时检测到了其他死亡和抗生素耐药风险因素。